Journal list menu
Export Citations
Download PDFs
ISSUE INFORMATION
LETTER TO THE JOURNAL
Open Access
oa
Loss of SMARCB1 evokes targetable epigenetic vulnerabilities in epithelioid sarcoma
- Pages: 494-499
- First Published: 20 January 2025
Open Access
oa
Circulating tumor cells share RNA modules with early embryo trophectoderm and with metastatic cancer
- Pages: 500-504
- First Published: 23 January 2025
REVIEW
Open Access
oa
Cuproplasia and cuproptosis, two sides of the coin
- Pages: 505-524
- First Published: 25 January 2025
LETTER TO THE JOURNAL
Open Access
oa
Evaluation of cervical cancer screening strategies in women living with HIV in Thailand
- Pages: 525-528
- First Published: 29 January 2025
REVIEW
Open Access
oa
Breaking barriers: Smart vaccine platforms for cancer immunomodulation
- Pages: 529-571
- First Published: 03 February 2025
LETTER TO THE JOURNAL
Open Access
oa
Sunitinib in metastatic renal cell carcinoma: clinical outcomes across risk groups in a Turkish Oncology Group Kidney Cancer Consortium
- Pages: 572-576
- First Published: 10 February 2025
REVIEW
Open Access
oa
Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities
- Pages: 577-607
- First Published: 13 February 2025
ORIGINAL ARTICLE
Open Access
oa
Helicobacter pylori CagA elevates FTO to induce gastric cancer progression via a “hit-and-run” paradigm
- Pages: 608-631
- First Published: 17 February 2025
LETTER TO THE JOURNAL
Open Access
oa
Neoadjuvant chemotherapy plus anlotinib in the treatment of resectable head and neck squamous cell carcinoma: A pilot phase II trial
- Pages: 632-636
- First Published: 19 February 2025